(Q41492063)

1 October 2017

title

Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus (English)

1 reference

1 October 2017

0 references

1 reference

1 reference

Chao-Hung Hung

1

1 reference

1 October 2017

Tsung-Hui Hu

2

1 reference

1 October 2017

Sheng-Nan Lu

3

1 reference

1 October 2017

Fang-Ying Kuo

4

1 reference

1 October 2017

Chien-Hung Chen

5

1 reference

1 October 2017

Jing-Houng Wang

6

1 reference

1 October 2017

Chao-Min Huang

7

1 reference

1 October 2017

Chuan-Mo Lee

8

1 reference

1 October 2017

Chih-Yun Lin

9

1 reference

1 October 2017

Yi-Hao Yen

10

1 reference

1 October 2017

Yi-Chun Chiu

11

1 reference

1 October 2017

language of work or name

English

0 references

publication date

11 August 2015

1 reference

International Journal of Cancer

1 October 2017

published in

1 reference

1 October 2017

volume

138

1 reference

1 October 2017

issue

3

1 reference

1 October 2017

page(s)

714-720

1 reference

1 October 2017

cites work

Hepatocellular carcinoma

1 reference

Epidemiological characteristics and risk factors of hepatocellular carcinoma

21 January 2018

1 reference

Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival

21 January 2018

1 reference

Natural history of chronic hepatitis B REVEALed

21 January 2018

1 reference

Strategies for the management of hepatocellular carcinoma

21 January 2018

1 reference

Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome

21 January 2018

1 reference

Management of hepatocellular carcinoma

21 January 2018

1 reference

MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target

21 January 2018

1 reference

MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?

21 January 2018

1 reference

Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance

21 January 2018

1 reference

Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma

21 January 2018

1 reference

Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection

21 January 2018

1 reference

Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study

21 January 2018

1 reference

Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma

21 January 2018

1 reference

Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis

21 January 2018

1 reference

Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study

21 January 2018

1 reference

miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1.

21 January 2018

1 reference

Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C.

21 January 2018

1 reference

Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection

21 January 2018

1 reference

Circulating microRNA-22 correlates with microRNA-122 and represents viral replication and liver injury in patients with chronic hepatitis B.

21 January 2018

1 reference

MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway

21 January 2018

1 reference

The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans

21 January 2018

1 reference

Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer

21 January 2018

1 reference

Circulating cell-free cancer-testis MAGE-A RNA, BORIS RNA, let-7b and miR-202 in the blood of patients with breast cancer and benign breast diseases

21 January 2018

1 reference

miR221/222 in cancer: their role in tumor progression and response to therapy

21 January 2018

1 reference

miR-221 overexpression contributes to liver tumorigenesis

21 January 2018

1 reference

miR-21-mediated tumor growth

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.29802

1 reference

1 October 2017

1 reference